
Security and aerospace company Northrop Grumman (NYSE:NOC) met Wall Street’s revenue expectations in Q3 2026, with sales up 6.7% year on year to $11.12 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $44 billion at the midpoint. Its non-GAAP profit of $7.89 per share was 9.9% above analysts’ consensus estimates.
Is now the time to buy NOC? Find out in our full research report (it’s free for active Edge members).
Northrop Grumman’s third quarter was marked by strong execution across its key programs, as evidenced by a significant increase in its order backlog and robust operating performance. Management highlighted successful program progress in both aeronautics and defense systems, driven by higher production volumes on major contracts like the F-35 and the continued ramp-up of the B-21 Raider. CEO Kathy Warden specifically pointed to “record backlog” and disciplined program execution, noting the company’s ability to deliver on commitments and meet evolving customer needs in a dynamic threat environment.
Looking ahead, Northrop Grumman’s leadership emphasized that future growth will be underpinned by accelerating production on franchise programs such as Sentinel and B-21, as well as new product developments in microelectronics and autonomous systems. Management cited the company’s growing international opportunities and the potential to extend advanced technology into commercial markets. Warden stated, “We are investing to rapidly expand our munitions and missile capacity to meet operational needs and increased demand,” while also signaling that the company is evaluating strategic alternatives to scale its microelectronics business for both defense and commercial applications.
Management attributed Q3 performance to strong demand for its major platforms, growing international interest, and new technology introductions, while emphasizing progress on strategic production ramps and portfolio investments.
Northrop Grumman’s outlook centers on the scaling of large franchise programs, new product commercialization, and margin expansion, with international demand and defense budgets serving as critical themes.
In the coming quarters, the StockStory team will be watching (1) the pace at which Northrop Grumman converts its substantial backlog into revenue through production ramps on B-21, Sentinel, and new missile systems, (2) progress on the commercialization and strategic alternatives for its microelectronics and quantum technologies, and (3) the rate of international order growth and execution on new contract awards. Monitoring margin trends as development programs transition to production will also be a key signpost for long-term profitability.
Northrop Grumman currently trades at $533.49, up from $510.65 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.